3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
8
Unknown
6
Recruiting
6
Active not recruiting
3
Withdrawn
2
Not yet recruiting
2
Terminated
1
No longer available
1
Sponsor Class
INDUSTRY
3
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Breast Neoplasms
332
Neoplasms
221
Prostatic Neoplasms
197
Carcinoma, Non-Small-Cell Lung
156
Lung Neoplasms
134
Pancreatic Neoplasms
118
Colorectal Neoplasms
102
Neoplasm Metastasis
100
Carcinoma, Hepatocellular
96
Leukemia, Myeloid, Acute
94
Multiple Myeloma
91
Brain Neoplasms
89
Lymphoma
86
Head and Neck Neoplasms
76
Melanoma
73
Ovarian Neoplasms
72
Leukemia
71
Leukemia, Lymphocytic, Chronic, B-Cell
69
Glioblastoma
69
Precursor Cell Lymphoblastic Leukemia-Lymphoma
66
Colonic Neoplasms
61
Recurrence
59
Lymphoma, Non-Hodgkin
54
Rectal Neoplasms
50
Hematologic Neoplasms
50
Lymphoma, Follicular
49
Glioma
49
Squamous Cell Carcinoma of Head and Neck
47
Lymphoma, Large B-Cell, Diffuse
47
Carcinoma, Renal Cell
46
Interventions
apalutamide
1
abiraterone
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
OTHER
×
Prostatic Neoplasms, Castration-Resistant
×
Clear all
NCT02866916
2021-01-20
PROSTIRNA
Institut Claudius Regaud
Phase 1
Withdrawn
NCT03173859
2020-11-18
AERA
University of Athens
Phase 2
Withdrawn